These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 8986693)

  • 1. Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.
    Seifer DB; Lambert-Messerlian G; Hogan JW; Gardiner AC; Blazar AS; Berk CA
    Fertil Steril; 1997 Jan; 67(1):110-4. PubMed ID: 8986693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
    Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
    Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Women with declining ovarian reserve may demonstrate a decrease in day 3 serum inhibin B before a rise in day 3 follicle-stimulating hormone.
    Seifer DB; Scott RT; Bergh PA; Abrogast LK; Friedman CI; Mack CK; Danforth DR
    Fertil Steril; 1999 Jul; 72(1):63-5. PubMed ID: 10428149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of day 3 estradiol on in vitro fertilization outcome.
    Smotrich DB; Widra EA; Gindoff PR; Levy MJ; Hall JL; Stillman RJ
    Fertil Steril; 1995 Dec; 64(6):1136-40. PubMed ID: 7589666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibin A and inhibin B reflect ovarian function in assisted reproduction but are less useful at predicting outcome.
    Hall JE; Welt CK; Cramer DW
    Hum Reprod; 1999 Feb; 14(2):409-15. PubMed ID: 10099988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Day 5 inhibin B serum concentrations as predictors of assisted reproductive technology outcome in cycles stimulated with gonadotrophin-releasing hormone agonist-gonadotrophin treatment.
    Peñarrubia J; Balasch J; Fábregues F; Carmona F; Casamitjana R; Moreno V; Calafell JM; Vanrell JA
    Hum Reprod; 2000 Jul; 15(7):1499-504. PubMed ID: 10875856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of inhibins and activin in women undergoing stimulation with recombinant follicle-stimulating hormone for in vitro fertilization treatment.
    Casper FW; Seufert RJ; Schaffrath M; Pollow K
    Fertil Steril; 2001 Jan; 75(1):32-7. PubMed ID: 11163813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibin B predicts oocyte number and the ratio IGF-I/IGFBP-1 may indicate oocyte quality during ovarian hyperstimulation for in vitro fertilization.
    Fried G; Remaeus K; Harlin J; Krog E; Csemiczky G; Aanesen A; Tally M
    J Assist Reprod Genet; 2003 May; 20(5):167-76. PubMed ID: 12812459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum inhibin A and inhibin B in healthy prepubertal, pubertal, and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels.
    Sehested A; Juul AA; Andersson AM; Petersen JH; Jensen TK; Müller J; Skakkebaek NE
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1634-40. PubMed ID: 10770209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Basal concentrations of oestradiol may predict the outcome of in-vitro maturation in regularly menstruating women.
    Mikkelsen AL; Andersson AM; Skakkebaek NE; Lindenberg S
    Hum Reprod; 2001 May; 16(5):862-7. PubMed ID: 11331629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibin B on the day of HCG-administration is a predictive factor for failure in assisted reproduction cycles.
    Engel JB; Felberbaum RE; Junge K; Reissmann T; Diedrich K
    Arch Gynecol Obstet; 2003 Oct; 268(4):278-80. PubMed ID: 14504869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of predictive values of inhibins A and B, and plasma estradiol in IVF patients treated with GnRH agonists and recombinant FSH].
    Millot F; Antoine JM; Merviel P; Mathieu E; Carpeau J; Uzan S
    Gynecol Obstet Fertil; 2002 Jan; 30(1):36-41. PubMed ID: 11875863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Day 5 inhibin B levels in a treatment cycle are predictive of IVF outcome.
    Fawzy M; Lambert A; Harrison RF; Knight PG; Groome N; Hennelly B; Robertson WR
    Hum Reprod; 2002 Jun; 17(6):1535-43. PubMed ID: 12042274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
    Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
    Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic assays of inhibin B, anti-Mullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome.
    Eldar-Geva T; Ben-Chetrit A; Spitz IM; Rabinowitz R; Markowitz E; Mimoni T; Gal M; Zylber-Haran E; Margalioth EJ
    Hum Reprod; 2005 Nov; 20(11):3178-83. PubMed ID: 16113044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: a study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles.
    Klein NA; Illingworth PJ; Groome NP; McNeilly AS; Battaglia DE; Soules MR
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2742-5. PubMed ID: 8675606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization.
    Licciardi FL; Liu HC; Rosenwaks Z
    Fertil Steril; 1995 Nov; 64(5):991-4. PubMed ID: 7589648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum inhibin B levels measured early during FSH administration for IVF may be of value in predicting the number of oocytes to be retrieved in normal and low responders.
    Eldar-Geva T; Margalioth EJ; Ben-Chetrit A; Gal M; Robertson DM; Healy DL; Diamant YZ; Spitz IM
    Hum Reprod; 2002 Sep; 17(9):2331-7. PubMed ID: 12202421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Correlation between serum inhibin B level after treatment with gonadotropin releasing hormone agonist and outcome of in vitro fertilization-embryo transfer].
    Lin WQ; Yang HY; Lin JJ; Chen X; Ye BL
    Zhonghua Fu Chan Ke Za Zhi; 2009 Apr; 44(4):260-2. PubMed ID: 19570462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.
    Loumaye E; Engrand P; Howles CM; O'Dea L
    Fertil Steril; 1997 May; 67(5):889-99. PubMed ID: 9130895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.